Nickel oral hyposensitization in patients with systemic nickel allergy syndrome

Background: This is the first randomized, double-blind, placebo-controlled trial (EUDRACT No. 2009-013923-43) evaluating nickel oral hyposensitizing treatment (NiOHT) in patients with “systemic nickel allergy syndrome” (SNAS), characterized by Ni-allergic contact dermatitis and systemic reactions af...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Gioacchino, Mario, Ricciardi, Luisa, De Pità, Ornella, Minelli, Mauro, Patella, Vincenzo, Voltolini, Susanna, Di Rienzo, Valerio, Braga, Marina, Ballone, Enzo, Mangifesta, Rocco, Schiavino, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673509/
https://www.ncbi.nlm.nih.gov/pubmed/24256166
http://dx.doi.org/10.3109/07853890.2013.861158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673509/
https://www.ncbi.nlm.nih.gov/pubmed/24256166
http://dx.doi.org/10.3109/07853890.2013.861158

Ejemplares similares